Site icon pharmaceutical daily

Short: Sycomore Asset Management’s share of Biocartis trigers transparency act

Biocartis's Idylla

Biocartis's Idylla

Biocartis Group NV said on Monday, in accordance with the Belgian Transparency Act, that Sycomore Asset Management now holds 3.01% of the voting rights in Biocartis. As a result, it has crossed the notification threshold of 3%.

The Belgian Transparency Act regulates the disclosure of major shareholdings in issuers whose shares are admitted to trading on a regulated market, that it received a transparency notification dated December 8, 2016, indicating that as a result of the acquisition of voting securities on December 7, 2016.

Pursuant to the Belgian Transparency Act and the articles of association of Biocartis, a notification to the company and the Belgian Financial Services and Markets Authority (‘FSMA’) is required by all natural and legal persons in each case where the percentage of voting rights in the Company held by such persons reaches, exceeds or falls below the threshold of 3%, 5%, 10%, and every subsequent multiple of 5%, of the total number of voting rights in the company.

Exit mobile version